Adverum Biotechnologies to Host a Conference Call and Webcast to Report Second Quarter 2019 Financial Results and Provide Corporate Updates
Individuals can participate in the conference call by dialing 1-866-420-8347 (domestic) or 1-409-217-8241 (international), and refer to the “Adverum Biotechnologies Second Quarter 2019 Earnings Call.” The webcast will be accessible under Events and Presentations in the Investors section of the Company's website. The archived audio webcast will be available on the Adverum website following the call, and will be available for 30 days.
Adverum is a clinical-stage gene therapy company targeting unmet medical needs in ocular diseases. Adverum develops gene therapy product candidates designed to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company has collaboration agreements with
Investor and Media Inquiries: Investors:
Amy Figueroa, CFA Investor Relations Consultant email@example.com 650-823-2704 Lee M. Stern, CFA Solebury Trout firstname.lastname@example.org 646-378-2922 Media: Joshua R. MansbachSolebury Trout email@example.com 646-378-2964
Source: Adverum Biotechnologies, Inc.